Wockhardt to raise capacity of hepatitis-B vaccineIllustrative image – not actual.

Wockhardt Rhein Biopharm Ltd. plans to raise the capacity of Hepatitis-B vaccine by eight times it current production with the next one and half years. Ultimately, the company plans to have a capacity of 50 million doses per year.

 

The company also plans to set up a biotechnology centre Waluj in Maharashtra for the production of the vaccine and human insulin.

← All latest storiesBack to top →